Method and kit for detecting, or determining the quantity of, beta-lactam penicillins
View Patent ↗The invention provides a hapten comprising a 6-[D-α-aminoacetamido] penicillin derivative crosslinked at the α-amino group with a substituted or unsubstituted phenyldicarbaldehyde. In addition, the invention provides an immunogen comprising the aforementioned hapten coupled to an antigenicity-conferring carrier material, a conjugate comprising the aforementioned hapten coupled to a labelling agent, as well as, antibodies raised against the aforementioned immunogen and capable of binding with at least one structural epitope of an intact β-lactam ring.
1. A hapten comprising a 6-[D-α-aminoacetamido] penicillin derivative crosslinked at the α-amino group with a substituted or unsubstituted phenyldicarbaldehyde selected from the group consisting of substituted or unsubstituted phthalaldehyde, substituted or unsubstituted isophthalaldehyde and substituted or unsubstituted terephthalaldehyde.
2. A hapten according to claim 1 , wherein the phenyldicarbaldehyde is a substituted or unsubstituted terephthalaldehyde.
3. A process for preparing a hapten, wherein a substituted or unsubstituted phenyldicarbaldehyde selected from the group consisting of substituted or unsubstituted phthalaldehyde, substituted or unsubstituted isophthalaldehyde, and substituted or unsubstituted terephthalaldehyde, or a mixture thereof, is reacted with a 6-[D-α-aminoacetamido] penicillin derivative in a solvent selected from the group consisting of dimethylformamide and dimethylsulfoxide.
4. An immunogen comprising a hapten, wherein said hapten comprises a 6-[D-α-aminoacetamido] penicillin derivative crosslinked at the α amino group with a substituted or unsubstituted phenyldicarbaldehyde selected from the group consisting of substituted or unsubstituted phthalaldehyde, substituted or unsubstituted isophthalaldehyde, and substituted or unsubstituted terephthalaldehyde, or a mixture thereof, coupled, through a terminal aldehyde on the substituted or unsubstituted phenyldicarbaldehyde, to an antigenicity-conferring carrier material.
5. The immunogen of claim 4 , wherein the carrier material is a protein, a protein fragment, a synthetic polypeptide or a semi-synthetic polypeptide.
6. Antibodies raised against an immunogen, wherein said immunogen comprises a hapten, wherein said hapten comprises a 6-[D-α-aminoacetamido] penicillin derivative crosslinked at the α-amino group with a substituted or unsubstituted phenyldicarbaldehyde selected from the group consisting of substituted or unsubstituted phthalaldehyde, substituted or unsubstituted isophthalaldehyde, and substituted or unsubstituted terephthalaldehyde, or a mixture thereof, coupled, through a terminal aldehyde on the substituted or unsubstituted phenyldicarbaldehyde, to an antigenicity-conferring carrier material.
7. The antibodies of claim 6 , wherein said antibodies are fixed on a backing substrate.
8. A process of preparing antibodies, the process comprising the steps of immunising an animal by repeated administration of an immunogen, wherein said immunogen comprises a hapten, wherein said hapten comprises a 6-[D-α-aminoacetamido] penicillin derivative crosslinked at the α-amino group with a substituted or unsubstituted phenyldicarbaldehyde selected from the group consisting of substituted or unsubstituted phthalaldehyde, substituted or unsubstituted isophthalaldehyde, and substituted or unsubstituted terephthalaldehyde, or a mixture thereof, coupled, through a terminal aldehyde on the substituted or unsubstituted phenyldicarbaldehyde, to an antigenicity-conferring carrier material, and collecting the resulting serum antibodies from the immunised animal.
9. The process of claim 8 , wherein the process further comprises fixing said serum antibodies to a backing substrate.
10. A conjugate comprising a hapten, wherein said hapten comprises a 6-[D-α-aminoacetamido] penicillin derivative crosslinked at the α-amino group with a substituted or unsubstituted phenyldicarbaldehyde selected from the group consisting of substituted or unsubstituted phthalaldehyde, substituted or unsubstituted isophthalaldehyde, and substituted or unsubstituted terephthalaldehyde, or a mixture thereof, covalently bonded, through a terminal aldehyde on the substituted or unsubstituted phenyldicarbaldehyde, to a labelling agent which is detectable.
11. The conjugate of claim 10 , wherein the labelling agent is an enzyme, a luminescent substance, a radioactive substance, or a mixture thereof.
12. A method for detecting, or determining the quantity of, β-lactam penicillins in a sample, the method comprising contacting the sample with a conjugate according to claim 10 , or a mixture thereof, and with antibodies, raised against an immunogen, wherein said immunogen comprises a hapten comprising a 6-[D-α-aminoacetamido] penicillin derivative crosslinked at the α-amino group with a substituted or unsubstituted phenyldicarbaldehyde selected from the group consisting of substituted or unsubstituted phthalaldehyde, substituted or unsubstituted isophthalaldehyde and substituted or unsubstituted terephthalaldehyde, or a mixture thereof, coupled, through a terminal aldehyde on the substituted or unsubstituted phenyldicarbaldehyde, to an antigenicity-conferring carrier material, or a mixture of said antibodies; detecting, or determining the quantity of, bound conjugate; and deducing from a calibration curve the presence, or amount of, β-lactam penicillins in the sample.
13. A kit for detecting, or determining the quantity of, β-lactam penicillins, the kit including a conjugate according to claim 10 , or a mixture thereof, and antibodies raised against an immunogen, wherein said immunogen comprises a hapten comprising a 6-[D-α-aminoacetamido] penicillin derivative crosslinked at the α-amino group with a substituted or unsubstituted phenyldicarbaldehyde selected from the group consisting of substituted or unsubstituted phthalaldehyde, substituted or unsubstituted isophthalaldehyde and substituted or unsubstituted terephthalaldehyde, or a mixture thereof, coupled, through a terminal aldehyde on the substituted or unsubstituted phenyldicarbaldehyde, to an antigenicity-conferring carrier material, or a mixture of said antibodies.
14. The hapten of claim 2 , wherein the phenyldicarbaldehyde is an unsubstituted terephthalaldehyde.
15. The process of claim 3 , wherein the phenyldicarbaldehyde is a substituted or unsubstituted terephthalaldehyde.
16. The process of claim 15 , wherein the phenyldicarbaldehyde is an unsubstituted terephthalaldehyde.
17. The immunogen of claim 4 , wherein the phenyldicarbaldehyde is a substituted or unsubstituted terephthalaldehyde.
18. The immunogen of claim 17 , wherein the phenyldicarbaldehyde is an unsubstituted terephthalaldehyde.
19. The antibodies of claim 6 , wherein the phenyldicarbaldehyde is a substituted or unsubstituted terephthalaldehyde.
20. The antibodies of claim 19 , wherein the phenyldicarbaldehyde is an unsubstituted terephthalaldehyde.
21. The antibodies of claim 6 , wherein said antibodies are capable of binding with at least one structural epitope of an intact β-lactam ring.
22. The process of claim 8 , wherein the phenyldicarbaldehyde is a substituted or unsubstituted terephthalaldehyde.
23. The process of claim 22 , wherein the phenyldicarbaldehyde is an unsubstituted terephthalaldehyde.
24. The conjugate of claim 10 , wherein the phenyldicarbaldehyde is a substituted or unsubstituted terephthalaldehyde.
25. The conjugate of claim 24 , wherein the phenyldicarbaldehyde is an unsubstituted terephthalaldehyde.
26. The conjugate of claim 11 , wherein the enzyme is a peroxidase.
27. The conjugate of claim 26 , wherein the peroxidase is horseradish peroxidase.
28. The conjugate of claim 11 , wherein the luminescent substance is a bioluminescent substance, a chemiluminescent substance or a fluorescent substance.